1. Home
  2. LGL vs CRIS Comparison

LGL vs CRIS Comparison

Compare LGL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • CRIS
  • Stock Information
  • Founded
  • LGL 1917
  • CRIS 2000
  • Country
  • LGL United States
  • CRIS United States
  • Employees
  • LGL N/A
  • CRIS N/A
  • Industry
  • LGL Industrial Machinery/Components
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LGL Technology
  • CRIS Health Care
  • Exchange
  • LGL Nasdaq
  • CRIS Nasdaq
  • Market Cap
  • LGL 31.5M
  • CRIS 32.8M
  • IPO Year
  • LGL N/A
  • CRIS 2000
  • Fundamental
  • Price
  • LGL $6.50
  • CRIS $3.17
  • Analyst Decision
  • LGL
  • CRIS Strong Buy
  • Analyst Count
  • LGL 0
  • CRIS 3
  • Target Price
  • LGL N/A
  • CRIS $23.00
  • AVG Volume (30 Days)
  • LGL 4.4K
  • CRIS 34.1K
  • Earning Date
  • LGL 03-31-2025
  • CRIS 02-18-2025
  • Dividend Yield
  • LGL N/A
  • CRIS N/A
  • EPS Growth
  • LGL 66.76
  • CRIS N/A
  • EPS
  • LGL 0.07
  • CRIS N/A
  • Revenue
  • LGL $4,130,000.00
  • CRIS $10,259,000.00
  • Revenue This Year
  • LGL N/A
  • CRIS N/A
  • Revenue Next Year
  • LGL N/A
  • CRIS N/A
  • P/E Ratio
  • LGL $98.87
  • CRIS N/A
  • Revenue Growth
  • LGL 26.49
  • CRIS 0.44
  • 52 Week Low
  • LGL $4.86
  • CRIS $2.86
  • 52 Week High
  • LGL $7.00
  • CRIS $17.49
  • Technical
  • Relative Strength Index (RSI)
  • LGL 47.37
  • CRIS 42.84
  • Support Level
  • LGL $6.60
  • CRIS $3.05
  • Resistance Level
  • LGL $7.00
  • CRIS $3.55
  • Average True Range (ATR)
  • LGL 0.26
  • CRIS 0.22
  • MACD
  • LGL -0.04
  • CRIS -0.00
  • Stochastic Oscillator
  • LGL 33.33
  • CRIS 20.00

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: